title: Modification of immune response in mice by ciprofloxacin.
abstract: Some studies have suggested that the addition of ciprofloxacin to in vitro cultures of mitogen-stimulated lymphocytes exerts inhibitory effects on cell cycle progression and immunoglobulin (Ig) secretion. We tested the effects of this drug on some immunity parameters in BALB/c mice. Mice treated intraperitoneally with ciprofloxacin (10 mg/kg of body weight per day) for 3 consecutive days and immunized with sheep erythrocytes 24 h after the last injection showed significant suppression of hemolytic IgG-forming cells, whereas the response of IgM-forming cells remained unchanged. When treatment lasted 7 days the response of antibody-forming cells was not modified. When the 3-day treatment was started at 24 h after immunization with sheep erythrocytes, the response of IgM-forming cells was increased, whereas the response of IgG-forming cells was suppressed. Delayed-type hypersensitivity to sheep erythrocytes was significantly suppressed in animals that received the 3-day treatment with ciprofloxacin and were immunized subcutaneously 24 h after the last injection. In vitro proliferation of lymphocytes from ciprofloxacin-treated mice in response to either lipopolysaccharide or concanavalin A was also suppressed. Leukopenia and an increase in the level of granulocyte-macrophage colony-forming cells in bone marrow were also observed in ciprofloxacin-treated mice. These results, together with those from other reports, suggest that modification of the biological responses by ciprofloxacin is a complex phenomenon that may be influenced by several factors.
authors.affiliation: Departamento de Microbiología, Facultad de Farmacia, Universidad de Granada, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Jimenez-Valera
authors.forename: A
authors.initials: A
authors.lastname: Sampedro
authors.forename: E
authors.initials: E
authors.lastname: Moreno
authors.forename: A
authors.initials: A
authors.lastname: Ruiz-Bravo
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D002452:Cell Count; D002478:Cells, Cultured; D002939:Ciprofloxacin / Q000276:immunology*; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018448:Models, Immunological; D013154:Spleen / Q000187:drug effects / Q000276:immunology
chemical_list: D002939:Ciprofloxacin